Sanofi, Medtronic join on diabetes drugs, devices

French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of drugs and devices for diabetes care.

The two major companies announced Saturday the "global strategic alliance," which they said was aimed at improving experience and results for people with diabetes around the world. The companies say the initial priorities will be developing drug-device combinations and providing care-management services to simplify .

Paris-based Sanofi has expertise in developing insulin drugs while Minneapolis-based Medtronic makes insulin pumps and devices for monitoring glucose to control blood sugar.

According to the World Health Organization, an estimated 347 million people worldwide have diabetes. In the U.S., about 30 million people have the disease.


Explore further

Sanofi sues Eli Lilly for patent infringement

© 2014 The Associated Press. All rights reserved.

Citation: Sanofi, Medtronic join on diabetes drugs, devices (2014, June 14) retrieved 20 June 2019 from https://medicalxpress.com/news/2014-06-sanofi-medtronic-diabetes-drugs-devices.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more